Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126410381 | 12641038 | 1 | I | 20160727 | 20160810 | 20160810 | EXP | IR-MLMSERVICE-20160721-0343311-1 | IR-ALKEM LABORATORIES LIMITED-IR-ALKEM-2016-00111 | ALKEM | 67.00 | YR | M | Y | 0.00000 | 20160810 | CN | GB | IR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126410381 | 12641038 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 1 G, BID | 91249 | 1 | G | Q12H | ||||||||
| 126410381 | 12641038 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 126410381 | 12641038 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | 1 MG, BID | 0 | 1 | MG | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126410381 | 12641038 | 1 | Immunosuppression |
| 126410381 | 12641038 | 2 | Immunosuppression |
| 126410381 | 12641038 | 3 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126410381 | 12641038 | OT |
| 126410381 | 12641038 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126410381 | 12641038 | Cytomegalovirus infection | |
| 126410381 | 12641038 | Skin ulcer | |
| 126410381 | 12641038 | Transplant dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |